Can Apollo Hospitals’ Strong Growth and Expansion Plans Drive a 28% Upside?

Synopsis: Apollo Hospitals Enterprise Limited gets a Buy rating from Citi on strong growth, expansion, and improving margins, with digital and HealthCo businesses supporting future earnings momentum.

This Large-cap Healthcare Stock, engaged in providing healthcare services, including hospitals, pharmacies, diagnostics, digital health platforms, and health insurance solutions across India, is in focus after Citi gave a Buy target of Rs. 9,600, which has an upside potential of 27.63 percent.

With a market capitalization of Rs. 1,08,148.35 crore, the shares of Apollo Hospitals Enterprise Limited closed at Rs. 7,521.55 per equity share, down nearly 0.36 percent from its previous day’s close price of Rs. 7,548.40. 

What is the News?

Citi, a prominent brokerage firm, has recommended a “Buy” call on Apollo Hospitals Enterprise Limited with a target price of Rs. 9,600 per share, indicating an upside potential of 27.63 percent from its current price of Rs. 7,521.55 per share.

Citi maintains a Buy rating on Apollo Hospitals Enterprise Limited, backed by strong growth visibility across its hospital and healthcare businesses. The brokerage expects the hospital segment, including both existing and new facilities, to deliver steady revenue growth of around 16-17 percent in FY27 and FY28, with healthy margins in the range of 24-25 percent.

The company’s expansion plans are progressing well, with new hospital capacity likely to break even by the end of FY27. Citi also expects these new additions to start contributing positively to earnings, with EBITDA contribution estimated at around 8-10 percent by FY28, supporting overall profitability.

On the operational front, external challenges remain manageable. The impact of disruptions in the Middle East is seen as minimal, with recovery expected in the coming quarters. At the same time, patient volumes from Bangladesh are improving. While consumable costs have risen due to INR depreciation, the impact is largely being passed on, protecting margins.

Additionally, Apollo’s digital platform Apollo 24/7 is nearing breakeven by Q1FY27. HealthCo is also growing strongly at around 17-18 percent CAGR. The planned Keimed merger and potential listing could further unlock value by building a large consumer healthcare platform.

Hospital Network

Apollo Hospitals has a strong hospital network with a total of 76 facilities. It operates 47 owned hospitals, 6 managed hospitals, and 23 day surgery centers (AHLL). The company has a total capacity of 10,325 beds, showing its large scale and presence across regions.

Out of this, around 9,561 beds are currently operational, indicating high utilization levels. Owned hospitals contribute the majority with 8,836 beds, while managed hospitals and day care centers add smaller but stable capacity. This strong infrastructure supports future growth and helps Apollo meet rising healthcare demand efficiently.

Company Overview

Apollo Hospitals Enterprise Limited is a major Indian private healthcare company headquartered in Chennai, Tamil Nadu. Founded in 1983 by Dr. Prathap C. Reddy, it pioneered corporate hospital networks in India and has grown into one of Asia’s largest integrated healthcare providers, spanning hospitals, pharmacies, and digital health services.

Recent Quarter Results

Coming into financial highlights, Apollo Hospitals Enterprise Limited’s revenue has increased from Rs. 5,527 crore in Q3 FY25 to Rs. 6,477 crore in Q3 FY26, which has grown by 17.19 percent. The net profit has also grown by 36.15 percent from Rs. 379 crore in Q3 FY25 to Rs. 516 crore in Q3 FY26. Apollo Hospitals Enterprise Limited’s revenue and net profit have grown at a CAGR of 14.15 percent and 28.35 percent, respectively, over the last five years.

In terms of return ratios, the company’s ROCE and ROE stand at 16.6 percent and 18.4 percent, respectively. Apollo Hospitals Enterprise Limited has an earnings per share (EPS) of Rs. 125, and its debt-to-equity ratio is 0.88x.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Can Apollo Hospitals’ Strong Growth and Expansion Plans Drive a 28% Upside? appeared first on Trade Brains.